Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06475300
What this trial is testing

BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal CarcinomaSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Large-scale testing (Phase 3)Not Yet RecruitingNCT06861777
What this trial is testing

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
YIN LI 474
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Testing effectiveness (Phase 2)Looking for participantsNCT05705492
What this trial is testing

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Biliary Tract CarcinomaAdvanced Esophageal Carcinoma+7 more
OHSU Knight Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT00813072
What this trial is testing

Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
PharmaEngine 135
Testing effectiveness (Phase 2)Study completedNCT00445861
What this trial is testing

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Not applicableStudy completedNCT02366611
What this trial is testing

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer

Who this might be right for
Cancer of Head and Neck
University of Michigan 11
Testing effectiveness (Phase 2)Study completedNCT00737438
What this trial is testing

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT04508816
What this trial is testing

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514767
What this trial is testing

Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)
Prof. Lars Olaf Cardell 60
Testing effectiveness (Phase 2)Study completedNCT00765011
What this trial is testing

TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer

Who this might be right for
Head and Neck Cancer
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 94
Not applicableNot Yet RecruitingNCT07457099
What this trial is testing

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Oral Squamous Cell CarcinomaLocally Advanced Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT06673693
What this trial is testing

Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)HNSCC
Sun Yat-sen University 24
Testing effectiveness (Phase 2)UnknownNCT00774319
What this trial is testing

TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radboud University Medical Center 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04651634
What this trial is testing

MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients

Who this might be right for
Head and Neck Squamous Cell CarcinomaOral Mucositis
MitoImmune Therapeutics 60
Large-scale testing (Phase 3)Study completedNCT02480114
What this trial is testing

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Who this might be right for
Malignant Head and Neck NeoplasmMucositisRadiation-Induced Disorder
Vanderbilt-Ingram Cancer Center 79
Early research (Phase 1)Study completedNCT04417465
What this trial is testing

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 101
Testing effectiveness (Phase 2)Study completedNCT03092934
What this trial is testing

AK-01 (LY3295668) in Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisTriple Negative Breast Neoplasms+4 more
Eli Lilly and Company 13
Testing effectiveness (Phase 2)WithdrawnNCT00636298
What this trial is testing

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Who this might be right for
Esophageal Carcinoma
Emory University
Next Page